Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Lung inflammatory injury and tissue repair (Jul 2023)
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact

Lymphatic vessel valves require RASA1 for development and function

Ras GTPase activating proteins (RasGAPs) control the activation of Ras, a small GTP-binding protein that regulates signal transduction pathways involved in cell growth, survival, and differentiation. Inactivating mutations the RasGAP RASA1 cause a blood and lymphatic vessel (LV) disorder known as capillary malformation-arteriovenous malformation, though exactly how loss of RASA1 function contributes to LV leakage is unclear.

This week in the JCI, research led by Philip King at University of Michigan Medical School reports that LV development and function critically depends on RASA1 activity. Ablation of RASA1 in adult mice led to specific defects in lymphatic valves that impaired the efficiency of LV pumping. Valve closure tests revealed that RASA1-deficient lymphatic vessels failed to prevent back-leak across valves. Moreover, ablating RASA1 in embryos impaired LV valve development. Together, these findings support an essential role for RASA1 in both LV formation and maintenance. 

The accompanying video visualizes LV responses to increases in downstream pressure. In the top panel, as pressure increases, LV valves in wildtype mice rapidly close to prevent backflow. In the bottom panel, valve failure in RASA1-deficient mice results in backflow into the upstream regions of the LV.

Published May 22, 2017, by Elyse Dankoski

Scientific Show Stopper

Related articles

RASA1 regulates the function of lymphatic vessel valves in mice
Philip E. Lapinski, … , Michael J. Davis, Philip D. King
Philip E. Lapinski, … , Michael J. Davis, Philip D. King
Published May 22, 2017
Citation Information: J Clin Invest. 2017;127(7):2569-2585. https://doi.org/10.1172/JCI89607.
View: Text | PDF
Research Article Vascular biology

RASA1 regulates the function of lymphatic vessel valves in mice

  • Text
  • PDF
Abstract

Capillary malformation–arteriovenous malformation (CM-AVM) is a blood and lymphatic vessel (LV) disorder that is caused by inherited inactivating mutations of the RASA1 gene, which encodes p120 RasGAP (RASA1), a negative regulator of the Ras small GTP-binding protein. How RASA1 mutations lead to the LV leakage defects that occur in CM-AVM is not understood. Here, we report that disruption of the Rasa1 gene in adult mice resulted in loss of LV endothelial cells (LECs) specifically from the leaflets of intraluminal valves in collecting LVs. As a result, valves were unable to prevent fluid backflow and the vessels were ineffective pumps. Furthermore, disruption of Rasa1 in midgestation resulted in LEC apoptosis in developing LV valves and consequently failed LV valvulogenesis. Similar phenotypes were observed in induced RASA1-deficient adult mice and embryos expressing a catalytically inactive RASA1R780Q mutation. Thus, RASA1 catalytic activity is essential for the function and development of LV valves. These data provide a partial explanation for LV leakage defects and potentially other LV abnormalities observed in CM-AVM.

Authors

Philip E. Lapinski, Beth A. Lubeck, Di Chen, Abbas Doosti, Scott D. Zawieja, Michael J. Davis, Philip D. King

×
Advertisement

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts